CHICAGO — Acetaminophen suppressed antitumor immunity in a cohort of patients with cancer, according to study results presented during ASCO Annual Meeting.
Researchers recommended caution when prescribing acetaminophen among patients with cancer who are treated with immune checkpoint inhibitors.
“Acetaminophen is the first-line strategy to manage mild-to-moderate pain among patients with advanced cancer,” Antoine Italiano, MD, PhD, professor and head of the early phase trials and sarcoma units at Institute Bergonié in Bordeaux, France, said during his presentation. “However,